We have located links that may give you full text access.
Tissue resident memory CD8 + T cells mediate salivary gland damage in a murine model of Sjögren's syndrome.
Arthritis & Rheumatology 2018 July 24
OBJECTIVE: Although a role for CD4+ T cells in the pathology of Sjögren's syndrome (SS) has been documented, the pathogenic significance of CD8+ T cells is unclear. The aim of this study is to investigate the role of CD8+ T cells in the development of SS.
METHODS: Flow cytometry and immunofluorescence were utilized to detect T cell infiltration within the labial glands of patients with primary SS. In parallel p40-/- CD25-/- mice were used as a murine model of SS. In addition CD4, CD8a and IFN-γ KO mice were crossed with p40-/- CD25-/- mice respectively to study the pathogenic significance of specific lineage subpopulations including functional salivary, histopathological and serological data. CD8+ T cell specific depletion antibody was used to evaluate this potential therapeutic strategy.
RESULTS: CD8+ T cells with tissue resident memory phenotype outnumbered CD4+ T cells in the labial gland of SS patients and were primarily co-localized with saliva duct epithelial cells and acinar cells. Furthermore, infiltrated CD8+ T cells with resident phenotype CD69+ CD103+/- with a significant elevation of IFN-γ production were dominant in the submandibular gland of this SS murine model. CD8a knockout abrogated the development of SS in these mice. Knockout of IFN-γ decreased CD8+ T cell infiltration and gland destruction. More importantly, depletion of CD8+ T cells fully protected mice from SS even after the onset of disease.
CONCLUSIONS: Our data reveal pathogenic significance of CD8+ T cells in the salivary gland pathology in SS. Treatment directed against CD8+ T cells may be a rational therapy for human SS. This article is protected by copyright. All rights reserved.
METHODS: Flow cytometry and immunofluorescence were utilized to detect T cell infiltration within the labial glands of patients with primary SS. In parallel p40-/- CD25-/- mice were used as a murine model of SS. In addition CD4, CD8a and IFN-γ KO mice were crossed with p40-/- CD25-/- mice respectively to study the pathogenic significance of specific lineage subpopulations including functional salivary, histopathological and serological data. CD8+ T cell specific depletion antibody was used to evaluate this potential therapeutic strategy.
RESULTS: CD8+ T cells with tissue resident memory phenotype outnumbered CD4+ T cells in the labial gland of SS patients and were primarily co-localized with saliva duct epithelial cells and acinar cells. Furthermore, infiltrated CD8+ T cells with resident phenotype CD69+ CD103+/- with a significant elevation of IFN-γ production were dominant in the submandibular gland of this SS murine model. CD8a knockout abrogated the development of SS in these mice. Knockout of IFN-γ decreased CD8+ T cell infiltration and gland destruction. More importantly, depletion of CD8+ T cells fully protected mice from SS even after the onset of disease.
CONCLUSIONS: Our data reveal pathogenic significance of CD8+ T cells in the salivary gland pathology in SS. Treatment directed against CD8+ T cells may be a rational therapy for human SS. This article is protected by copyright. All rights reserved.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app